Malnutrition Screening by Muscle Ultrasound in Patients Requiring Mechanical Ventilation in Intensive Care Unit
NCT ID: NCT02564159
Last Updated: 2022-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
286 participants
INTERVENTIONAL
2015-10-30
2022-08-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Skeletal muscle is central to cytokine regulation and it contributes 85% of total body glucose clearance. Some research findings suggest that muscle wasting is a smoldering inflammatory state partially driven by cytokines and oxidative stress but these conclusions need to be investigated in context of critically ill patients and perioperative settings.
The investigators search to determine impact of inflammatory biomarkers (IL-1, IL-6 and TNF-α) and oxidative stress (evaluated by quantifying the global anti-oxidative defenses in patient with an original method (Patrol® test) based on the use of excited molecular oxygen (singlet oxygen) as a source of ROS on erosion of lean body mass measure with quadriceps muscle ultrasound. Consequently, in an ancillary study of the MALICUS project, the investigators wish to investigate interaction between acute inflammation and muscle wasting.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Prognostic Value of the Thickness of the Quadriceps and Abdominal Muscles Measured by Ultrasound for 28-day Mortality in Postoperative ICU Patients
NCT05276921
Early Assessment of Quadriceps Muscle Recovery by Dynamometry and 3D Ultrasound in Intensive Care Patients Under Invasive Mechanical Ventilation
NCT07069959
Ultrasound to Evaluate the Quadriceps Muscle Wasting
NCT02562495
Abdominal Muscle Thickness in Mechanically Ventilated Patients
NCT03567564
Correlation Between Muscle Strength and Thickness in Critically Ill Patients
NCT06289244
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High-risk patient for malnutrition acquired in ICU
Patients admitted in ICU and treated with mechanical ventilation with expected duration of 48 hours or more
Measure of quadriceps thickness with ultrasonography and albumin/prealbumin levels
* Evaluation of quadriceps diameter on the anterior aspect of the thigh using the mid-distance between the anterior superior iliac spine and the upper pole of the patella ;
* Biospecimen collection: Blood samples (prealbumin levels, C-reactive protein, Interleukin-1, Interleukin-6, TNF-alpha and PATROL test™)collection of albumin and prealbumin levels
Controls patients: Elective surgery
Controls patients: Elective surgery (neurosurgery, thoracic surgery, vascular surgery)
\- Patients admitted in a post-operative care unit of the university hospital of Nantes after elective surgery with expected duration ICU length of stay \< 48 hours
Measure of quadriceps thickness with ultrasonography and albumin/prealbumin levels
* Evaluation of quadriceps diameter on the anterior aspect of the thigh using the mid-distance between the anterior superior iliac spine and the upper pole of the patella ;
* Biospecimen collection: Blood samples (prealbumin levels, C-reactive protein, Interleukin-1, Interleukin-6, TNF-alpha and PATROL test™)collection of albumin and prealbumin levels
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Measure of quadriceps thickness with ultrasonography and albumin/prealbumin levels
* Evaluation of quadriceps diameter on the anterior aspect of the thigh using the mid-distance between the anterior superior iliac spine and the upper pole of the patella ;
* Biospecimen collection: Blood samples (prealbumin levels, C-reactive protein, Interleukin-1, Interleukin-6, TNF-alpha and PATROL test™)collection of albumin and prealbumin levels
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. MALICUS Study
\- Patient requiring invasive mechanical ventilation
\- Expected duration of ventilation longer than 48 hours
\- Age \> 18 years
* Subjects affiliated with an appropriate social security system
\- Invasive mechanical ventilation started for more than 48 hours
\- Patient severely malnourished at baseline (at least one of the following criteria)
* Prealbuminemia \< 0,11 g/L
* BMI ≤ 18,5 (or ≤ 22 beyond 70 years)
* Unintentional weight loss \> 5% in the previous month or \> 10% in the last 6 months - Glomerular nephropathy history/nephrotic syndrome, chronic renal failure (MDRD \< 30 ml/min), liver cirrhosis or exudative gastro-enteropathy - Glucocorticoid (\> 10 mg / day of prednisone equivalent ) long-term therapy ( \> 1 month) - Impossible ultrasound measure of anterolateral diameter for the two quadriceps muscles
\- Neuromuscular disease that can cause muscle atrophy at a lower limb, without any support in the ICU
2. Control group - BIOBANK-MALICUS
* Elective surgery requiring an ICU stay (neurosurgery, vascular surgery, thoracic surgery)
* Expected duration of ventilation shorter than 48 hours
• Elective surgery with cardiopulmonary bypass
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baxter Healthcare Corporation
INDUSTRY
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bertrand ROZEC, Pr
Role: PRINCIPAL_INVESTIGATOR
Nantes University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nantes University Hospital
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC14_0424
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.